This protocol is judged by an institutional evaluation board, an independent team that testimonials any medical trials involving people. If a review involves a Routine I drug, after the board approves the protocol as ethical, the scientists have to apply for an investigational new drug (IND) number within the FDA.With all the doses packaged and lab… Read More